On Friday Feb. 28th, we hosted a conference call on the potential impact of COVID-19 on the Drug & Med Supply Chains with Premier Inc's President Michael Alkire, leader of Premier's efforts to address drug shortages, and David Hargraves, SVP Supply Chain.

With $61bn of annual GPO purchasing volume across 2,500+ hospitals and substantial contract manufacturing operations, Premier is unique positioned to help us take a closer look at the potential impact of shortages on Med Tech, Diagnostics, Consumables and Pharmaceuticals. 
  
 This call is relevant for investors in:

• Hospitals and Alt. Site Facility Operators
• Med Devices Manufacturers
• Diagnostics and Consumables Manufacturers
• Brand and Generic Drug Manufacturers
• Drug Distributors and Pharmacies